February 29, 2024
Regional media highlighted the University of Cincinnati Cancer Center being the first site in the Midwest enrolling patients in a new Phase 2 clinical trial testing a vaccine to treat pancreatic cancer.
June 9, 2022
Dermatology Times featured recent research by University of Cincinnati researchers that showed a low recurrence rate of nail squamous cell carcinoma when treated with surgical approaches other than amputation.
May 22, 2023
The University of Cincinnati Cancer Center's Emily Curran recently provided commentary, highlighted by MedPage Today, on a study that showed a combination of antibody-drug conjugate and chemotherapy treatments were promising for older patients with B-cell acute lymphocytic leukemia.